Oral Live Cholera Vaccines Market Report

Europe Oral Live Cholera Vaccines Market Size, Status and Forecast 2014-2026

  • POSTDATE：Jan 14, 2020
  • PAGES：149
  • REPORT CODE：GMM435317
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Oral Live Cholera Vaccines market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 2.2% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Oral Live Cholera Vaccines Market Segmentations:

    By Player:

    • Shantha Biotechnics Limited

    • Ceva Asia

    • PaxVax

    • Celldex Therapeutics

    • Merck

    • Valneva

    By Type:

    • Dukoral

    • Shanchol

    • Vaxchora

    • Others

    By End-User:

    • Hospital

    • Scientific Research

    • Others

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Oral Live Cholera Vaccines Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Oral Live Cholera Vaccines Market Size and Growth Rate of Dukoral from 2014 to 2026

    • 1.3.2 Europe Oral Live Cholera Vaccines Market Size and Growth Rate of Shanchol from 2014 to 2026

    • 1.3.3 Europe Oral Live Cholera Vaccines Market Size and Growth Rate of Vaxchora from 2014 to 2026

    • 1.3.4 Europe Oral Live Cholera Vaccines Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Oral Live Cholera Vaccines Market Size and Growth Rate of Hospital from 2014 to 2026

    • 1.4.2 Europe Oral Live Cholera Vaccines Market Size and Growth Rate of Scientific Research from 2014 to 2026

    • 1.4.3 Europe Oral Live Cholera Vaccines Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Oral Live Cholera Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Oral Live Cholera Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Oral Live Cholera Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Oral Live Cholera Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Oral Live Cholera Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Oral Live Cholera Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Oral Live Cholera Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Oral Live Cholera Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Oral Live Cholera Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oral Live Cholera Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Oral Live Cholera Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Oral Live Cholera Vaccines Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Oral Live Cholera Vaccines Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Oral Live Cholera Vaccines by Major Types

      • 3.4.1 Market Size and Growth Rate of Dukoral

      • 3.4.2 Market Size and Growth Rate of Shanchol

      • 3.4.3 Market Size and Growth Rate of Vaxchora

      • 3.4.4 Market Size and Growth Rate of Others

    4 Segmentation of Oral Live Cholera Vaccines Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Oral Live Cholera Vaccines by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Oral Live Cholera Vaccines for Hospital

      • 4.4.2 Market Size and Growth Rate of Oral Live Cholera Vaccines for Scientific Research

      • 4.4.3 Market Size and Growth Rate of Oral Live Cholera Vaccines for Others

    5 Market Analysis by Major Regions

    • 5.1 Europe Oral Live Cholera Vaccines Production Analysis by Top Regions

    • 5.2 Europe Oral Live Cholera Vaccines Consumption Analysis by Top Regions

    • 5.3 Europe Oral Live Cholera Vaccines Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Oral Live Cholera Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Oral Live Cholera Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.3 France Oral Live Cholera Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Oral Live Cholera Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Oral Live Cholera Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Oral Live Cholera Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Oral Live Cholera Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Oral Live Cholera Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Oral Live Cholera Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oral Live Cholera Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Oral Live Cholera Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Oral Live Cholera Vaccines Production, Import, Consumption and Export Analysis

    6 Product Circulation of Oral Live Cholera Vaccines Market among Top Countries

    • 6.1 Top 5 Export Countries in Oral Live Cholera Vaccines Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Oral Live Cholera Vaccines Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Oral Live Cholera Vaccines Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Oral Live Cholera Vaccines Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Oral Live Cholera Vaccines Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Oral Live Cholera Vaccines Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Oral Live Cholera Vaccines Landscape Analysis

    • 7.1 Germany Oral Live Cholera Vaccines Landscape Analysis by Major Types

    • 7.2 Germany Oral Live Cholera Vaccines Landscape Analysis by Major End-Users

    8. UK Oral Live Cholera Vaccines Landscape Analysis

    • 8.1 UK Oral Live Cholera Vaccines Landscape Analysis by Major Types

    • 8.2 UK Oral Live Cholera Vaccines Landscape Analysis by Major End-Users

    9. France Oral Live Cholera Vaccines Landscape Analysis

    • 9.1 France Oral Live Cholera Vaccines Landscape Analysis by Major Types

    • 9.2 France Oral Live Cholera Vaccines Landscape Analysis by Major End-Users

    10. Italy Oral Live Cholera Vaccines Landscape Analysis

    • 10.1 Italy Oral Live Cholera Vaccines Landscape Analysis by Major Types

    • 10.2 Italy Oral Live Cholera Vaccines Landscape Analysis by Major End-Users

    11. Spain Oral Live Cholera Vaccines Landscape Analysis

    • 11.1 Spain Oral Live Cholera Vaccines Landscape Analysis by Major Types

    • 11.2 Spain Oral Live Cholera Vaccines Landscape Analysis by Major End-Users

    12. Poland Oral Live Cholera Vaccines Landscape Analysis

    • 12.1 Poland Oral Live Cholera Vaccines Landscape Analysis by Major Types

    • 12.2 Poland Oral Live Cholera Vaccines Landscape Analysis by Major End-Users

    13. Russia Oral Live Cholera Vaccines Landscape Analysis

    • 13.1 Russia Oral Live Cholera Vaccines Landscape Analysis by Major Types

    • 13.2 Russia Oral Live Cholera Vaccines Landscape Analysis by Major End-Users

    14. Switzerland Oral Live Cholera Vaccines Landscape Analysis

    • 14.1 Switzerland Oral Live Cholera Vaccines Landscape Analysis by Major Types

    • 14.2 Switzerland Oral Live Cholera Vaccines Landscape Analysis by Major End-Users

    15. Turkey Oral Live Cholera Vaccines Landscape Analysis

    • 15.1 Turkey Oral Live Cholera Vaccines Landscape Analysis by Major Types

    • 15.2 Turkey Oral Live Cholera Vaccines Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oral Live Cholera Vaccines Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oral Live Cholera Vaccines Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oral Live Cholera Vaccines Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oral Live Cholera Vaccines Landscape Analysis by Top Countries

      • 16.3.1 Denmark Oral Live Cholera Vaccines Market Volume and Growth Rate

      • 16.3.2 Finland Oral Live Cholera Vaccines Market Volume and Growth Rate

      • 16.3.3 Norway Oral Live Cholera Vaccines Market Volume and Growth Rate

      • 16.3.4 Sweden Oral Live Cholera Vaccines Market Volume and Growth Rate

      • 16.3.6 Iceland Oral Live Cholera Vaccines Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Oral Live Cholera Vaccines Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Oral Live Cholera Vaccines Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Oral Live Cholera Vaccines Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Oral Live Cholera Vaccines Landscape Analysis by Top Countries

      • 17.3.1 Belgium Oral Live Cholera Vaccines Market Volume and Growth Rate

      • 17.3.2 Netherlands Oral Live Cholera Vaccines Market Volume and Growth Rate

      • 17.3.3 Luxembourg Oral Live Cholera Vaccines Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Oral Live Cholera Vaccines Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Oral Live Cholera Vaccines Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Oral Live Cholera Vaccines Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Oral Live Cholera Vaccines Landscape Analysis by Top Countries

      • 18.3.1 Estonia Oral Live Cholera Vaccines Market Volume and Growth Rate

      • 18.3.2 Latvia Oral Live Cholera Vaccines Market Volume and Growth Rate

      • 18.3.3 Lithuania Oral Live Cholera Vaccines Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Shantha Biotechnics Limited

      • 19.1.1 Shantha Biotechnics Limited Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Ceva Asia

      • 19.2.1 Ceva Asia Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 PaxVax

      • 19.3.1 PaxVax Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Celldex Therapeutics

      • 19.4.1 Celldex Therapeutics Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Merck

      • 19.5.1 Merck Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Valneva

      • 19.6.1 Valneva Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    The List of Tables and Figures (Totals 113 Figures and 137 Tables)

    • Figure Product Picture

    • Figure Europe Oral Live Cholera Vaccines Market Size and Growth Rate of Dukoral from 2014 to 2026

    • Figure Europe Oral Live Cholera Vaccines Market Size and Growth Rate of Shanchol from 2014 to 2026

    • Figure Europe Oral Live Cholera Vaccines Market Size and Growth Rate of Vaxchora from 2014 to 2026

    • Figure Europe Oral Live Cholera Vaccines Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Europe Oral Live Cholera Vaccines Market Size and Growth Rate of Hospital from 2014 to 2026

    • Figure Europe Oral Live Cholera Vaccines Market Size and Growth Rate of Scientific Research from 2014 to 2026

    • Figure Europe Oral Live Cholera Vaccines Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Germany Oral Live Cholera Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure UK Oral Live Cholera Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure France Oral Live Cholera Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Oral Live Cholera Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Oral Live Cholera Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Oral Live Cholera Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Oral Live Cholera Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Oral Live Cholera Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Oral Live Cholera Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Oral Live Cholera Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Oral Live Cholera Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oral Live Cholera Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Oral Live Cholera Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Oral Live Cholera Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Oral Live Cholera Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Oral Live Cholera Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Oral Live Cholera Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Oral Live Cholera Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Oral Live Cholera Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Oral Live Cholera Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Oral Live Cholera Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Oral Live Cholera Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Oral Live Cholera Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Oral Live Cholera Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Oral Live Cholera Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Oral Live Cholera Vaccines Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Oral Live Cholera Vaccines

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Oral Live Cholera Vaccines by Different Types from 2014 to 2026

    • Table Consumption Share of Oral Live Cholera Vaccines by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Dukoral

    • Figure Market Size and Growth Rate of Shanchol

    • Figure Market Size and Growth Rate of Vaxchora

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Oral Live Cholera Vaccines by Different End-Users from 2014 to 2026

    • Table Consumption Share of Oral Live Cholera Vaccines by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Hospital

    • Figure Market Size and Growth Rate of Scientific Research

    • Figure Market Size and Growth Rate of Others

    • Table Europe Oral Live Cholera Vaccines Production by Major Regions

    • Table Europe Oral Live Cholera Vaccines Production Share by Major Regions

    • Figure Europe Oral Live Cholera Vaccines Production Share by Major Countries and Regions in 2014

    • Table Europe Oral Live Cholera Vaccines Consumption by Major Regions

    • Table Europe Oral Live Cholera Vaccines Consumption Share by Major Regions

    • Table Germany Oral Live Cholera Vaccines Production, Import, Consumption and Export Analysis

    • Table UK Oral Live Cholera Vaccines Production, Import, Consumption and Export Analysis

    • Table France Oral Live Cholera Vaccines Production, Import, Consumption and Export Analysis

    • Table Italy Oral Live Cholera Vaccines Production, Import, Consumption and Export Analysis

    • Table Spain Oral Live Cholera Vaccines Production, Import, Consumption and Export Analysis

    • Table Poland Oral Live Cholera Vaccines Production, Import, Consumption and Export Analysis

    • Table Russia Oral Live Cholera Vaccines Production, Import, Consumption and Export Analysis

    • Table Switzerland Oral Live Cholera Vaccines Production, Import, Consumption and Export Analysis

    • Table Turkey Oral Live Cholera Vaccines Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oral Live Cholera Vaccines Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Oral Live Cholera Vaccines Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Oral Live Cholera Vaccines Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Oral Live Cholera Vaccines Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Oral Live Cholera Vaccines Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Oral Live Cholera Vaccines Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Oral Live Cholera Vaccines Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Oral Live Cholera Vaccines Consumption by Types from 2014 to 2026

    • Table Germany Oral Live Cholera Vaccines Consumption Share by Types from 2014 to 2026

    • Table Germany Oral Live Cholera Vaccines Consumption by End-Users from 2014 to 2026

    • Table Germany Oral Live Cholera Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table UK Oral Live Cholera Vaccines Consumption by Types from 2014 to 2026

    • Table UK Oral Live Cholera Vaccines Consumption Share by Types from 2014 to 2026

    • Table UK Oral Live Cholera Vaccines Consumption by End-Users from 2014 to 2026

    • Table UK Oral Live Cholera Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table France Oral Live Cholera Vaccines Consumption by Types from 2014 to 2026

    • Table France Oral Live Cholera Vaccines Consumption Share by Types from 2014 to 2026

    • Table France Oral Live Cholera Vaccines Consumption by End-Users from 2014 to 2026

    • Table France Oral Live Cholera Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Italy Oral Live Cholera Vaccines Consumption by Types from 2014 to 2026

    • Table Italy Oral Live Cholera Vaccines Consumption Share by Types from 2014 to 2026

    • Table Italy Oral Live Cholera Vaccines Consumption by End-Users from 2014 to 2026

    • Table Italy Oral Live Cholera Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Spain Oral Live Cholera Vaccines Consumption by Types from 2014 to 2026

    • Table Spain Oral Live Cholera Vaccines Consumption Share by Types from 2014 to 2026

    • Table Spain Oral Live Cholera Vaccines Consumption by End-Users from 2014 to 2026

    • Table Spain Oral Live Cholera Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Poland Oral Live Cholera Vaccines Consumption by Types from 2014 to 2026

    • Table Poland Oral Live Cholera Vaccines Consumption Share by Types from 2014 to 2026

    • Table Poland Oral Live Cholera Vaccines Consumption by End-Users from 2014 to 2026

    • Table Poland Oral Live Cholera Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Russia Oral Live Cholera Vaccines Consumption by Types from 2014 to 2026

    • Table Russia Oral Live Cholera Vaccines Consumption Share by Types from 2014 to 2026

    • Table Russia Oral Live Cholera Vaccines Consumption by End-Users from 2014 to 2026

    • Table Russia Oral Live Cholera Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Oral Live Cholera Vaccines Consumption by Types from 2014 to 2026

    • Table Switzerland Oral Live Cholera Vaccines Consumption Share by Types from 2014 to 2026

    • Table Switzerland Oral Live Cholera Vaccines Consumption by End-Users from 2014 to 2026

    • Table Switzerland Oral Live Cholera Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Oral Live Cholera Vaccines Consumption by Types from 2014 to 2026

    • Table Turkey Oral Live Cholera Vaccines Consumption Share by Types from 2014 to 2026

    • Table Turkey Oral Live Cholera Vaccines Consumption by End-Users from 2014 to 2026

    • Table Turkey Oral Live Cholera Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oral Live Cholera Vaccines Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oral Live Cholera Vaccines Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oral Live Cholera Vaccines Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oral Live Cholera Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oral Live Cholera Vaccines Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oral Live Cholera Vaccines Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Oral Live Cholera Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Oral Live Cholera Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Oral Live Cholera Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Oral Live Cholera Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Oral Live Cholera Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Oral Live Cholera Vaccines Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Oral Live Cholera Vaccines Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Oral Live Cholera Vaccines Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Oral Live Cholera Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Oral Live Cholera Vaccines Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Oral Live Cholera Vaccines Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Oral Live Cholera Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Oral Live Cholera Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Oral Live Cholera Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Oral Live Cholera Vaccines Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Oral Live Cholera Vaccines Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Oral Live Cholera Vaccines Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Oral Live Cholera Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Oral Live Cholera Vaccines Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Oral Live Cholera Vaccines Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Oral Live Cholera Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Oral Live Cholera Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Oral Live Cholera Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Shantha Biotechnics Limited

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shantha Biotechnics Limited

    • Figure Sales and Growth Rate Analysis of Shantha Biotechnics Limited

    • Figure Revenue and Market Share Analysis of Shantha Biotechnics Limited

    • Table Product and Service Introduction of Shantha Biotechnics Limited

    • Table Company Profile and Development Status of Ceva Asia

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ceva Asia

    • Figure Sales and Growth Rate Analysis of Ceva Asia

    • Figure Revenue and Market Share Analysis of Ceva Asia

    • Table Product and Service Introduction of Ceva Asia

    • Table Company Profile and Development Status of PaxVax

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of PaxVax

    • Figure Sales and Growth Rate Analysis of PaxVax

    • Figure Revenue and Market Share Analysis of PaxVax

    • Table Product and Service Introduction of PaxVax

    • Table Company Profile and Development Status of Celldex Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celldex Therapeutics

    • Figure Sales and Growth Rate Analysis of Celldex Therapeutics

    • Figure Revenue and Market Share Analysis of Celldex Therapeutics

    • Table Product and Service Introduction of Celldex Therapeutics

    • Table Company Profile and Development Status of Merck

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

    • Figure Sales and Growth Rate Analysis of Merck

    • Figure Revenue and Market Share Analysis of Merck

    • Table Product and Service Introduction of Merck

    • Table Company Profile and Development Status of Valneva

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Valneva

    • Figure Sales and Growth Rate Analysis of Valneva

    • Figure Revenue and Market Share Analysis of Valneva

    • Table Product and Service Introduction of Valneva

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US